Table 3.

Most commonly reported suspected drug products by patient age.

Drug product	ED visits for ADEs resulting in hospitalization
All patients (N = 18,918 hospitalized out of 61,855)	No. of Suspected Agents 26,335 (%)
Warfarin	2,611 (9.91)
Acetylsalicylic acid	1,523 (5.78)
Amoxicillin-clavulanate	898 (3.41)
Insulin glargine (short-acting)	602 (2.98)
Lorazepam	469 (1.78)
Metformin	466 (1.77)
Ketoprofen	418 (1.59)
Furosemide	401 (1.52)
Insulin lispro (rapid-acting)	368 (1.40)
Alprazolam	360 (1.37)
Clopidogrel	352 (1.34)
Ibuprofen	333 (1.26)
Levofloxacin	321 (1.22)
Diclofenac	315 (1.20)
Acenocoumarol	313 (1.19)
Patients aged ≤19 y (N = 880 hospitalized out of 6,012)	No. of suspected agents 1,162 (%)
Amoxicillin-clavulanate	83 (7.14)
Paracetamol	63 (5.42)
Ibuprofen	56 (4.82)
Ketoprofen	48 (4.13)
Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B	35 (3.01)
Pneumococcus, purified polysaccharides antigen conjugated	33 (2.84)
Lorazepam	32 (2.75)
Carbamazepine	23 (1.98)
Amoxicillin	22 (1.89)
Valproic acid	20 (1.72)
Ceftriaxone	19 (1.64)
Clarithromycin	19 (1.64)
Alprazolam	17 (1.46)
Clonazepam	15 (1.29)
Measles, combinations with mumps and rubella, live attenuated	14 (1.20)
Metoclopramide	14 (1.20)
Patients aged ≥65 y (N = 11,296 hospitalized out of 29,241)	No. of Suspected Agents 15,335 (%)
Warfarin	2,033 (15.19)
Acetylsalicylic acid	1,286 (8.38)
Insulin glargine (short-acting)	419 (2.73)
Metformin	377 (2.46)
Furosemide	349 (2.27)
Clopidogrel	302 (1.97)
Acenocoumarol	268 (1.75)
Metformina and sulfonylureas	258 (1.68)
Amoxicillin-clavulanate	246 (1.60)
Insulin lispro (rapid-acting)	240 (1.56)
Ramipril	217 (1.41)
Digoxin	213 (1.39)
Dabigatran	205 (1.34)
Levofloxacin	192 (1.25)
Glimepiride	184 (1.20)